IV iron use, by DOPPS country and cross-section

  N Ptnts Total N Wgtd %
DOPPS Country DOPPS Cross-section 329 507 65.8%
AusNZ D2(2002)
D3(2006) 377 493 76.0%
D3(2007) 350 465 75.7%
D4(2010) 173 257 68.2%
Belgium D2(2002) 473 536 87.8%
D3(2006) 434 491 88.0%
D3(2007) 336 404 84.0%
D4(2010) 350 417 83.7%
Canada D2(2002) 376 577 60.8%
D3(2006) 347 532 64.3%
D3(2007) 319 440 70.6%
D4(2010) 212 291 65.4%
France D2(2002) 328 507 64.6%
D3(2006) 380 542 72.2%
D3(2007) 413 543 76.2%
D4(2010) 253 350 72.9%
Germany D2(2002) 432 565 76.2%
D3(2006) 443 556 80.2%
D3(2007) 470 620 76.0%
D4(2010) 371 513 73.0%
Italy D2(2002) 296 561 55.2%
D3(2006) 329 508 64.1%
D3(2007) 340 538 65.4%
D4(2010) 285 417 69.0%
Japan D2(2002) 574 1,763 34.2%
D3(2006) 606 1,800 33.7%
D3(2007) 747 1,825 42.1%
D4(2010) 587 1,638 36.8%
Spain D2(2002) 475 601 79.0%
D3(2006) 508 646 79.5%
D3(2007) 440 546 81.6%
D4(2010) 417 544 77.0%
Sweden D2(2002) 434 546 79.8%
D3(2006) 458 535 87.0%
D3(2007) 416 507 82.3%
D4(2010) 338 436 76.5%
UK D2(2002) 410 553 75.7%
D3(2006) 337 434 73.1%
D3(2007) 285 348 81.3%
D4(2010) 287 359 80.5%
US D2(2002) 1,361 2,218 62.8%
D3(2006) 1,386 1,780 75.7%
D3(2007) 970 1,297 75.6%
D4(2010) 2,212 3,139 73.7%

Medications reported as prescribed in previous three months, among all patients

Please see additional methodological information in the Data Sources and Methods section.